Quick answer

MEDDIC is a complex-sales qualification framework covering Metrics, Economic Buyer, Decision Criteria, Decision Process, Identify Pain and Champion. It helps a team test whether an opportunity has measurable value, access to the person accountable for the economic decision, understood evaluation requirements, a realistic path to approval, a consequential problem and an internal advocate who can mobilize action. MEDDIC emerged at PTC in the 1990s; current training organizations differ on precise attribution and later variants. Use it as a dynamic evidence system rather than a stage sequence or checklist. Define proof levels, update elements as the buying group learns, expose unknowns in reviews, and connect evidence to next actions. MEDDPIC and MEDDPICC add paper process and, in some variants, competition.

What is MEDDIC?

MEDDIC is a qualification and opportunity-management framework for complex sales. It organizes six interdependent evidence areas that help teams decide whether an opportunity is real, what risks remain and which action can improve the buyer's decision.

It is commonly expanded as Metrics, Economic Buyer, Decision Criteria, Decision Process, Identify Pain and Champion. Some practitioners phrase the I as Identify Pain and others as Implicate Pain. Teams should define their language and behavior rather than argue over an acronym while applying different standards.

Origins and variants

MEDDIC was developed at enterprise software company PTC in the 1990s as teams studied what distinguished successful deals. Current training organizations broadly agree on that setting but differ on precise dates, contributors and ownership claims. State history cautiously and consult original participants where attribution matters.

The framework spread through enterprise technology sales because long, high-value decisions require more than contact activity and seller confidence. It gave managers a shared language for deal evidence and gaps.

The six MEDDIC elements

Metrics should be buyer-relevant, measurable and traceable to a baseline and method. The economic buyer is accountable for the economic decision, not automatically the highest title. Decision criteria describe how options will be judged; decision process describes how the judgment becomes authorization.

Identified pain means a verified condition important enough to justify change. A champion is an influential internal actor with a personal or organizational reason to help and demonstrated willingness to mobilize others. Friendliness, responsiveness or coaching the seller is not sufficient evidence.

Metrics

Translate the buyer's desired change into agreed operational or economic evidence.

  • What outcome would matter?
  • How will the buyer validate it?
Useful signals: Baseline, target, method, owner, source, range and uncertainty

Economic Buyer

Understand the person accountable for the final economic trade-off and how they decide.

  • Who can commit resources?
  • What outcomes and risks matter to them?
Useful signals: Role, access route, priorities, approval rights and evidence standard

Decision Criteria

Learn the formal and informal requirements used to compare options and the status quo.

  • What must the solution and supplier satisfy?
  • Who shapes each criterion?
Useful signals: Technical, commercial, legal, operational, strategic and relationship requirements

Decision Process

Map the sequence, participants, dependencies and validation events leading to a decision.

  • How does evaluation become approval?
  • Where can the process stop?
Useful signals: Stages, dates, owners, gates, procurement, paper process and no-decision risk

Identify Pain

Verify a consequential problem or opportunity and who experiences it.

  • What must change?
  • What happens if it does not?
Useful signals: Current state, impact, priority, root cause, affected roles and fit

Champion

Assess whether an internal person has influence, motivation and willingness to mobilize the decision.

  • Who benefits from change?
  • What action have they taken internally?
Useful signals: Access, credibility, information sharing, internal action, constructive challenge and mutual trust

How MEDDIC improves deal judgment

Complex deals fail through interdependent gaps. A serious problem without an approval path can stall; strong criteria without a champion can lose internal momentum; an executive meeting without measurable value can remain ceremonial. MEDDIC makes these dependencies discussable.

The method also separates buyer learning from seller activity. A proposal, demo or executive call matters only if it resolves a decision question or creates commitment. Managers can coach the missing evidence rather than prescribe more activity indiscriminately.

Build MEDDIC into the sales workflow

Define observable evidence levels for each element at important stages. For example, a metric may progress from seller hypothesis to buyer-confirmed baseline to approved business-case measure. Publish examples and non-examples drawn from the actual sales motion.

Research before discovery, ask purposeful questions, summarize understanding and seek permission for deeper work. Multi-thread responsibly across the buying group while keeping contacts informed. Use workshops, technical validation and mutual action plans only when they help the buyer decide.

  • MEDDIC terms defined locally
  • Stage-specific evidence levels documented
  • Metrics include baseline, method and owner
  • Economic buyer distinguished from senior title
  • Formal and informal criteria mapped
  • Decision process includes owners and gates
  • Pain verified with affected stakeholders
  • Champion assessed through observable action
  • Claims include source, date and confidence
  • Contradictions and unknowns visible
  • Paper and competition risks added when relevant
  • Managers coach next evidence, not box completion

MEDDIC example

PulseArchive's initial technical relationship is not enough to forecast a hospital-wide migration. MEDDIC exposes the need for clinically and operationally relevant measures, a multi-party criteria map and a formal path through security, finance and procurement.

The technical manager becomes a potential champion only through internal action. Economic-buyer access is linked to a useful assessment rather than demanded as proof of control. Open risks remain visible, which protects both forecast integrity and the hospital's decision.

PulseArchive is a hypothetical platform for migrating hospital imaging archives. A regional hospital group is considering modernization, but the initiative involves clinical operations, security, IT, finance and procurement, and the seller currently knows only an enthusiastic technical manager.

Pain and metrics

The team verifies workflow and continuity concerns with the affected owners. It jointly defines what a successful migration assessment would measure, including service continuity, retrieval validation, staff effort and migration risk, without inventing savings.

Criteria and process

Clinical, security and technical stakeholders document mandatory criteria. The decision map separates technical validation, security review, business-case approval, procurement and contracting, with named owners and realistic dependencies.

Economic buyer

The CIO is accountable for the investment trade-off, but direct access is earned through a reviewed assessment. The seller learns the CIO's concerns and evidence standard through documented meetings rather than relying on title alone.

Champion

The technical manager shares internal context and coordinates stakeholders, but the team tests champion behavior through actions. Enthusiasm alone is not treated as influence or authority.

Review

The opportunity review exposes open security evidence and procurement timing. The forecast remains cautious until those risks change, and a no-go assessment is an acceptable outcome if requirements cannot be met.

PulseArchive, the hospital group, stakeholders and outcomes are hypothetical. Real healthcare sales require verified evidence, confidentiality, applicable regulation and qualified technical and clinical review.

Measure adoption, evidence quality and outcomes

Measure whether eligible opportunities have current evidence, whether managers agree on evidence ratings, and whether next actions address real gaps. Completeness alone is weak because fabricated certainty can produce a perfect score.

Compare evidence states with stage aging, no decision, forecast error, win or loss and downstream customer outcomes. Segment by deal type and cohort. A champion may be essential in a large transformation but less relevant in a simple transactional renewal.

Use MEDDIC for coaching and cross-functional work

A deal review should ask what is known, how it is known, what contradicts it and what the buyer needs next. Leaders should make it safe to surface risk. If a red field automatically triggers punishment, sellers will make it green.

Product, security, legal, finance and implementation teams can own evidence or actions inside a complex deal. Clear engagement rules prevent sellers from promising internal resources prematurely and help specialists prioritize opportunities with genuine buyer commitment.

Marketing and enablement can create discovery guides, business-case methods, role maps and proof aligned with common gaps. Competitive and win-loss evidence should update criteria and competition guidance without exposing confidential information.

Preserve truth, privacy and buyer autonomy

Do not turn MEDDIC into covert political manipulation. Buying-role maps should support relevant coordination, not pressure, bypass or exploit individuals. Be clear about why introductions and data are requested.

Metrics must use defensible assumptions and show uncertainty. Avoid inventing costs, attributing value the product cannot deliver or coaching a champion to make unsupported internal claims. Protect confidential process, pricing and stakeholder information.

A champion has obligations to their organization, not to the seller. Respect a contact who changes position after new evidence. The most responsible outcome can be a delay or no purchase.

Limitations and common misuse

MEDDIC was shaped in complex enterprise selling and can be excessive for short, low-risk transactions. The administrative cost should match deal value and uncertainty. Use a lighter rubric where appropriate.

Common misuse includes declaring a friendly contact a champion, confusing titles with economic authority, copying seller-created metrics into the buyer's business case and treating a calendar as the decision process. Another failure is adding MEDDPICC fields without coaching or data governance.

MEDDIC cannot create product fit, credible proof or customer trust. It improves visibility and action only when leaders reward accurate risk and allow disqualification.

A complete MEDDIC record is not the goal. Current, sourced evidence that improves a mutual decision is the goal.

Frequently asked questions

What does MEDDIC stand for?

Metrics, Economic Buyer, Decision Criteria, Decision Process, Identify Pain and Champion.

What is the difference between MEDDIC and MEDDPICC?

MEDDPICC adds Paper Process and Competition to the original six elements. Some variants use slightly different spelling or grouping.

Is MEDDIC a sales process?

It is primarily a qualification and deal-evidence framework. It can support a sales process but does not replace discovery, positioning, negotiation or implementation workflows.

What makes someone a champion?

A champion has influence, a reason to support change and demonstrated willingness to mobilize the internal decision. Responsiveness or friendliness alone is not enough.

When should MEDDIC be used?

Use it when deal value, complexity, buying-group size and risk justify detailed evidence. Simpler transactions may need a lighter qualification system.

Sources and further reading

Explore related concepts